S&P 500

5.303,27

0,12%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Innovate Biopharmaceuticals Inc (INNT)
Innovate Biopharmaceuticals Inc (INNT) Notícias

INNT

Innovate Biopharmaceutic... (INNT)

Innovate Biopharmaceuticals Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:INNT

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
13/11/2019	10:00	PR Newswire (US)	RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Dise...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
08/11/2019	18:14	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
07/11/2019	18:46	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
07/10/2019	08:00	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
27/08/2019	19:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
13/08/2019	10:00	GlobeNewswire Inc.	Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac ...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
08/08/2019	17:30	GlobeNewswire Inc.	Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
15/07/2019	18:30	GlobeNewswire Inc.	Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings Release	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
15/07/2019	07:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
03/07/2019	18:04	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
03/07/2019	18:03	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
24/06/2019	08:00	GlobeNewswire Inc.	Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
10/06/2019	09:01	GlobeNewswire Inc.	Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac Disease	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
31/05/2019	17:05	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
20/05/2019	10:45	GlobeNewswire Inc.	Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Lar...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
17/05/2019	17:54	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
09/05/2019	09:01	GlobeNewswire Inc.	Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
01/05/2019	17:30	GlobeNewswire Inc.	Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
01/05/2019	10:12	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
29/04/2019	14:19	GlobeNewswire Inc.	Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-Market	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
29/04/2019	08:35	GlobeNewswire Inc.	Innovate Biopharmaceuticals Shows Larazotide is the First Drug, with its Novel Mechanism of Action of Re-normalizing the Inte...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
26/04/2019	18:15	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
26/04/2019	13:59	GlobeNewswire Inc.	Innovate Biopharmaceuticals First Quarter 2019 Financial Results and Operational Progress Updates - Webcast Details	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
11/04/2019	10:45	GlobeNewswire Inc.	Innovate Biopharmaceuticals Presents Oral Poster at European Association for the Study of the Liver (EASL) Demonstrating Posi...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
02/04/2019	08:00	GlobeNewswire Inc.	Innovate Biopharmaceuticals to Announce First Quarter 2019 Financial Results and to Provide Operational Progress Updates on A...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
26/03/2019	10:32	GlobeNewswire Inc.	Innovate Biopharmaceuticals Announces Collaboration with Institut Gustave Roussy to Study Regulation of Intestinal Permeabili...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
19/03/2019	08:45	GlobeNewswire Inc.	Innovate Biopharmaceuticals Reports Financing to Initiate the First Phase 3 Clinical Trial in Celiac Disease, Fiscal Year 201...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
18/03/2019	20:30	GlobeNewswire Inc.	Innovate Biopharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results and to Provide Corporate and Opera...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
18/03/2019	18:18	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:INNT	Innovate Biopharmaceuticals Inc
18/03/2019	09:51	GlobeNewswire Inc.	Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac...	NASDAQ:INNT	Innovate Biopharmaceuticals Inc